Skip to main content
Caplight Logo









Limnopharma

Limnopharma

Private
GranadaHealthcare & Life Scienceshttps://limnopharma.com/

Last Round

Convertible Debt

Oct 5, 2022

Total Funding Raised

$320,000

Company Overview

Limnopharma is a pharmaceutical company that develops new therapies for retinal diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

retinal disease treatmentsmall-molecule drugRetinitis Pigmentosadry AMDeye drop therapyAge-Related Macular Degenerationneuroprotective therapyanti-inflammatory therapyclinical-stage biotechdrug licensingnatural product derivativesophthalmologyrare disease therapyRP treatmentwet AMDDiabetic Retinopathy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Limnopharma Comparables

Compare Limnopharma with similar companies based on industry and business-model similarity.

Limnopharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Miramón Pharma S.L.
81%
Nacuity Pharmaceuticals, Inc.
80%
Belite Bio, Inc
77%

Limnopharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtOct 5, 2022
AcceleratorDec 23, 2021
GrantDec 20, 2020
SeedMar 1, 2019

Limnopharma Investors

Notable investors and investment history

Limnopharma investors
InvestorRounds
GENESIS VenturesSeries A, Seed
Center for Technological Development and InnovationGrant
AcexHealthAccelerator
Medex PartnersSeries A
La Fondation de l'AvenirSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 5, 2022

    Raised funding from Covirán S.C.A.

  • Dec 23, 2021

    $10K round led by AcexHealth

Limnopharma Filings

Explore SEC and related filing metadata, where available.

Limnopharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Limnopharma's valuation, stock price, and market status.

Is Limnopharma a public or private company?

Limnopharma is a private company.

What is the current stock price of Limnopharma?

Limnopharma is a private company with no public stock price. No recent secondary market data is available.

How much is Limnopharma worth (valuation)?

Valuation information for Limnopharma is not publicly available.

Can I buy Limnopharma stock?

Limnopharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Limnopharma's last funding round?

Limnopharma's most recent funding round was Convertible Debt on October 5, 2022.

Who are the main investors in Limnopharma?

Key investors in Limnopharma include GENESIS Ventures.

Will Limnopharma IPO soon?

No public IPO plans have been announced for Limnopharma.

How can I track Limnopharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Limnopharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGranada
Year Founded2019
Last FundingOct 5, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?